General Information of the Compound
Compound ID |
CP0041181
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-(3-Benzoylphenyl)propionic acid
Show/Hide
|
||||||||||||||||||
Synonyms |
(+-)-m-Benzoylhydratropic acid
2-(3-Benzoylphenyl)propanoic acid
2-(3-Benzoylphenyl)propionic acid
2-(m-Benzoylphenyl)propionic acid
2-[3-(benzoyl)phenyl]propanoic acid
2-[3-(phenylcarbonyl)phenyl]propanoic acid
2-[3-Benzoylphenyl]propionic acid
3-Benzoylhydratropic acid
Acide (benzoyl-3-phenyl)-2-propionique
Acide (benzoyl-3-phenyl)-2-propionique [French]
Actron
Alrheumat
Alrheumum
Alrheumun
Aneol
Arthril (TN)
Benzoylhydratropic Acid
Bi-Profnid (TN)
Capisten
Dexal
Epatec
Fastum
Fastum (TN)
Fastum Gel (TN)
Iso-K
K 1751
Kefenid
Keto (TN)
Ketoflam (TN)
Ketomex (TN)
Ketonal (TN)
Ketoprofen
Ketoprofen (JP15/USP/INN)
Ketoprofen [USAN:INN:BAN:JAN]
Ketoprofenas (TN)
Ketoprofene
Ketoprofene (TN)
Ketoprofene [INN-French]
Ketoprofeno
Ketoprofeno [INN-Spanish]
Ketoprofenum
Ketoprofenum (TN)
Ketoprofenum [INN-Latin]
Ketopron
Ketoprophene
Ketorin (TN)
Ketospray (TN)
L'Acide (benzoyl-3-phenyl)-2-propionique
Lasonil (TN)
Lertus
M-Benzoylhydratropic acid
Menamin
Meprofen
Oki (TN)
Orudis
Orudis (TN)
Orudis KT
Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen
Orugesic
Oruvail
Oruvail (TN)
Oscorel
Profenid
RP 19583
RP, 19,583
RP-19583
RP19583
RU 4733
Racemic-Ketoprofen
Toprec
Toprek
Zon (TN)
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H14O3
|
||||||||||||||||||
Molecular Weight |
254.285
|
||||||||||||||||||
Canonical SMILES |
CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)
Show/Hide
|
||||||||||||||||||
InChIKey |
DKYWVDODHFEZIM-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
172964-50-0
22161-86-0
22071-15-4
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01062, Prostaglandin G/H synthase 2
Protein ID: PT00901, Prostaglandin G/H synthase 2
Protein ID: PT04064, Solute carrier family 22 member 6
Protein ID: PT06206, Solute carrier family 22 member 7
Clinical Information about the Compound